210 related articles for article (PubMed ID: 27514862)
1. Workshop Report: Crystal City VI-Bioanalytical Method Validation for Biomarkers.
Arnold ME; Booth B; King L; Ray C
AAPS J; 2016 Nov; 18(6):1366-1372. PubMed ID: 27514862
[TBL] [Abstract][Full Text] [Related]
2. AAPS and US FDA Crystal City VI workshop on bioanalytical method validation for biomarkers.
Lowes S; Ackermann BL
Bioanalysis; 2016 Feb; 8(3):163-7. PubMed ID: 26795584
[TBL] [Abstract][Full Text] [Related]
3. Workshop report: Crystal City V--quantitative bioanalytical method validation and implementation: the 2013 revised FDA guidance.
Booth B; Arnold ME; DeSilva B; Amaravadi L; Dudal S; Fluhler E; Gorovits B; Haidar SH; Kadavil J; Lowes S; Nicholson R; Rock M; Skelly M; Stevenson L; Subramaniam S; Weiner R; Woolf E
AAPS J; 2015 Mar; 17(2):277-88. PubMed ID: 25549614
[TBL] [Abstract][Full Text] [Related]
4. 2019 White Paper On Recent Issues in Bioanalysis: FDA BMV Guidance, ICH M10 BMV Guideline and Regulatory Inputs (
Booth B; Stevenson L; Pillutla R; Buonarati M; Beaver C; Fraier D; Garofolo F; Haidar S; Islam R; James C; Kadavil J; Kavetska O; Li F; Satterwhite C; Savoie N; Subramaniam S; Tampal N; Thway T; Woolf E; Blaye OL; Andisik M; Briscoe C; Cape S; Dasgupta A; Fischer S; Haidar S; Hayes R; Kamerud J; Lima Santos GM; Nehls C; Soo C; Vinter S; Whale E; Xu K; Cho SJ; Edmison A; Kassim S; Rocha TC; Welink J; Amur S; Bandukwala A; Cherry E; Hopper S; Ishii-Watabe A; Kirshner S; Maher K; Pedras-Vasconcelos J; Saito Y; Saunders TS; Skibeli V; Verthelyi D; Wang YM; Yan H
Bioanalysis; 2019 Dec; 11(23):2099-2132. PubMed ID: 31833782
[TBL] [Abstract][Full Text] [Related]
5. 2019 White Paper on Recent Issues in Bioanalysis: FDA Immunogenicity Guidance, Gene Therapy, Critical Reagents, Biomarkers and Flow Cytometry Validation (Part 3 - Recommendations on 2019 FDA Immunogenicity Guidance, Gene Therapy Bioanalytical Challenges, Strategies for Critical Reagent Management, Biomarker Assay Validation, Flow Cytometry Validation & CLSI H62).
Piccoli S; Mehta D; Vitaliti A; Allinson J; Amur S; Eck S; Green C; Hedrick M; Hopper S; Ji A; Joyce A; Litwin V; Maher K; Mathews J; Peng K; Safavi A; Wang YM; Zhang Y; Amaravadi L; Palackal N; Thankamony S; Beaver C; Bame E; Emrich T; Grimaldi C; Haulenbeek J; Joyce A; Kakkanaiah V; Lanham D; Maher K; Mayer A; Trampont PC; Vermet L; Dakappagari N; Fleener C; Garofolo F; Rogers C; Tangri S; Xu Y; Liang M; Rajadhyaksha M; Richards S; Schweighardt B; Purushothama S; Baltrukonis D; Brumm J; Cherry E; Delcarpini J; Gleason C; Kirshner S; Kubiak R; Pan L; Partridge M; Pedras-Vasconcelos J; Qu Q; Skibeli V; Saunders TS; Staack RF; Stubenrauch K; Torri A; Verthelyi D; Yan H; Gorovits B; Palmer R; Milton M; Long B; Corsaro B; Farrokhi V; Fiscella M; Henderson N; Jawa V; McNally J; Murphy R; Waldner H; Yang TY
Bioanalysis; 2019 Dec; 11(24):2207-2244. PubMed ID: 31820675
[TBL] [Abstract][Full Text] [Related]
6. FDA seeks advice on track-and-trace systems.
Traynor K
Am J Health Syst Pharm; 2011 Apr; 68(7):552-4. PubMed ID: 21411794
[No Abstract] [Full Text] [Related]
7. Therapeutic protein drug-drug interactions: navigating the knowledge gaps-highlights from the 2012 AAPS NBC Roundtable and IQ Consortium/FDA workshop.
Kenny JR; Liu MM; Chow AT; Earp JC; Evers R; Slatter JG; Wang DD; Zhang L; Zhou H
AAPS J; 2013 Oct; 15(4):933-40. PubMed ID: 23794076
[TBL] [Abstract][Full Text] [Related]
8. Conference report: AAPS and US FDA Crystal City V meeting on Quantitative Bioanalytical Method Validation and Implementation: feedback from the EBF.
Smeraglia J; McDougall S; Elsby K; Companjen A; White S; Golob M; Brudny-Kloeppel M; Amsterdam Pv; Timmerman P
Bioanalysis; 2014 Mar; 6(6):729-32. PubMed ID: 24702107
[TBL] [Abstract][Full Text] [Related]
9. 8th GCC: consolidated feedback to US FDA on the 2013 draft FDA guidance on bioanalytical method validation.
Bower J; Fast D; Garofolo F; Gouty D; Hayes R; Lowes S; Nicholson R; LeLacheur R; Bravo J; Shoup R; Dumont I; Carbone M; Zimmer J; Ortuno J; Caturla MC; Datin J; Lansing T; Fatmi S; Struwe P; Sheldon C; Islam R; Yu M; Hulse J; Kamerud J; Lin J; Doughty J; Kurylak K; Tang D; Buonarati M; Blanchette A; Levesque A; Gagnon-Carignan S; Lin J; Ray G; Liu Y; Khan M; Xu A; El-Sulayman G; DiMarco C; Bouhajib M; Tacey D; Jenkins R; der Strate Bv; Briscoe C; Karnik S; Rhyne P; Garofolo W; Schultz G; Roberts A; Redrup M; DuBey I; Conliffe P; Pekol T; Hantash J; Cojocaru L; Allen M; Reuschel S; Watson A; Farrell C; Groeber E; Malone M; Nowatzke W; Fang X
Bioanalysis; 2014; 6(22):2957-63. PubMed ID: 25496252
[TBL] [Abstract][Full Text] [Related]
10. Quantitative bioanalytical methods validation and implementation: best practices for chromatographic and ligand binding assays.
Viswanathan CT; Bansal S; Booth B; DeStefano AJ; Rose MJ; Sailstad J; Shah VP; Skelly JP; Swann PG; Weiner R
Pharm Res; 2007 Oct; 24(10):1962-73. PubMed ID: 17458684
[TBL] [Abstract][Full Text] [Related]
11. Workshop Report: FDA Workshop on Improving Cardiotoxicity Assessment With Human-Relevant Platforms.
Pang L; Sager P; Yang X; Shi H; Sannajust F; Brock M; Wu JC; Abi-Gerges N; Lyn-Cook B; Berridge BR; Stockbridge N
Circ Res; 2019 Oct; 125(9):855-867. PubMed ID: 31600125
[TBL] [Abstract][Full Text] [Related]
12. Advancing Product Quality: a Summary of the Second FDA/PQRI Conference.
Yu LX; Akseli I; Allen B; Amidon G; Bizjak TG; Boam A; Caulk M; Doleski D; Famulare J; Fisher AC; Furness S; Hasselbalch B; Havel H; Hoag SW; Iser R; Johnson BD; Ju R; Katz P; Lacana E; Lee SL; Lostritto R; McNally G; Mehta M; Mohan G; Nasr M; Nosal R; Oates M; O'Connor T; Polli J; Raju GK; Ramanadham M; Randazzo G; Rosencrance S; Schwendeman A; Selen A; Seo P; Shah V; Sood R; Thien MP; Tong T; Trout BL; Tyner K; Vaithiyalingam S; VanTrieste M; Walsh F; Wesdyk R; Woodcock J; Wu G; Wu L; Yu L; Zezza D
AAPS J; 2016 Mar; 18(2):528-43. PubMed ID: 26860627
[No Abstract] [Full Text] [Related]
13. Assuring quality and performance of sustained and controlled release parenterals: AAPS workshop report, co-sponsored by FDA and USP.
Burgess DJ; Hussain AS; Ingallinera TS; Chen ML
Pharm Res; 2002 Nov; 19(11):1761-8. PubMed ID: 12458685
[TBL] [Abstract][Full Text] [Related]
14. Clinical biomarker validation.
Allinson JL
Bioanalysis; 2018 Jun; 10(12):957-968. PubMed ID: 29923754
[TBL] [Abstract][Full Text] [Related]
15. Regulatory watch: Evaluating the potential for digital submission of expedited premarket safety reports to the FDA.
Khozin S; Chuk M; Kim T; Kim G; Pazdur R; De S; Sahoo S
Nat Rev Drug Discov; 2016 Sep; 15(10):670-1. PubMed ID: 27681787
[No Abstract] [Full Text] [Related]
16. FDA 2011 process validation guidance: lifecycle compliance model.
Campbell C
PDA J Pharm Sci Technol; 2014; 68(2):185-91. PubMed ID: 24668605
[TBL] [Abstract][Full Text] [Related]
17. Workshop report and follow-up--AAPS Workshop on current topics in GLP bioanalysis: Assay reproducibility for incurred samples--implications of Crystal City recommendations.
Fast DM; Kelley M; Viswanathan CT; O'Shaughnessy J; King SP; Chaudhary A; Weiner R; DeStefano AJ; Tang D
AAPS J; 2009 Jun; 11(2):238-41. PubMed ID: 19381839
[TBL] [Abstract][Full Text] [Related]
18. 11th GCC Closed Forum: cumulative stability; matrix stability; immunogenicity assays; laboratory manuals; biosimilars; chiral methods; hybrid LBA/LCMS assays; fit-for-purpose validation; China Food and Drug Administration bioanalytical method validation.
Islam R; Briscoe C; Bower J; Cape S; Arnold M; Hayes R; Warren M; Karnik S; Stouffer B; Xiao YQ; van der Strate B; Sikkema D; Fang X; Tudoroniu A; Tayyem R; Brant A; Spriggs F; Barry C; Khan M; Keyhani A; Zimmer J; Caturla MC; Couerbe P; Khadang A; Bourdage J; Datin J; Zemo J; Hughes N; Fatmi S; Sheldon C; Fountain S; Satterwhite C; Colletti K; Vija J; Yu M; Stamatopoulos J; Lin J; Wilfahrt J; Dinan A; Ohorodnik S; Hulse J; Patel V; Garofolo W; Savoie N; Brown M; Papac D; Buonarati M; Hristopoulos G; Beaver C; Boudreau N; Williard C; Liu Y; Ray G; Warrino D; Xu A; Green R; Hayward-Sewell J; Marcelletti J; Sanchez C; Kennedy M; Charles JS; Bouhajib M; Nehls C; Tabler E; Tu J; Joyce P; Iordachescu A; DuBey I; Lindsay J; Yamashita J; Wells E
Bioanalysis; 2018 Apr; 10(7):433-444. PubMed ID: 29701066
[TBL] [Abstract][Full Text] [Related]
19. Method validation and measurement of biomarkers in nonclinical and clinical samples in drug development: a conference report.
Lee JW; Weiner RS; Sailstad JM; Bowsher RR; Knuth DW; O'Brien PJ; Fourcroy JL; Dixit R; Pandite L; Pietrusko RG; Soares HD; Quarmby V; Vesterqvist OL; Potter DM; Witliff JL; Fritche HA; O'Leary T; Perlee L; Kadam S; Wagner JA
Pharm Res; 2005 Apr; 22(4):499-511. PubMed ID: 15846456
[TBL] [Abstract][Full Text] [Related]
20. 2020 White Paper on Recent Issues in Bioanalysis: Vaccine Assay Validation, qPCR Assay Validation, QC for CAR-T Flow Cytometry, NAb Assay Harmonization and ELISpot Validation (
Corsaro B; Yang TY; Murphy R; Sonderegger I; Exley A; Bertholet S; Dakappagari N; Dessy F; Garofolo F; Kierstead L; Koch H; Sarikonda G; Savoie N; Siggers R; Solstad T; Lu Y; Milton M; Marshall JC; DelCarpini J; Gorovits B; Gupta S; Jesaitis L; Kamerud J; Kromminga A; Ma A; McNally J; Yan H; Wu B; Verthelyi D; Kirshner S; Pedras-Vasconcelos J; Rajadhyaksha M; Staack RF; Cherry E; Cludts I; Dahlbäck M; Gunn GR; Ishii-Watabe A; Jawa V; Kubiak R; Partridge M; Petrillo M; Pine SO; Poetzl J; Song S; Stebbins C; Wu Y; Zhang L; Kar S; Liang M; Abhari MR; Schweighardt B; Stubenrauch K; Xu Y
Bioanalysis; 2021 Mar; 13(6):415-463. PubMed ID: 33533276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
